Response to: 'Comment on: 'Idiopathic inflammatory myopathies and antisynthetase syndrome: contribution of antisynthetase antibodies to improve current classification criteria' by Greco et al' by Knitza et al
Open Access
- 1 July 2020
- journal article
- letter
- Published by Elsevier in Annals of the Rheumatic Diseases
- Vol. 79 (7) , e86
Abstract
We have with great interest read the letter entitled ‘Response to: ‘Idiopathic inflammatory myopathies and antisynthetase syndrome: contribution of antisynthetase antibodies to improve current classification criteria’ by Greco et al ’ by Knitza et al , to be published in the Annals of the Rheumatic Diseases .1 We appreciate the thoughtful comments made by the authors and agree on the importance of aminoacyl transfer RNA synthetase (ARS) autoantibodies, as well as other autoantibodies for correct classification of the associated diseases. The discussion stems from the European League Against Rheumatism (EULAR)/American College of Rheumatology (ACR) …Keywords
This publication has 5 references indexed in Scilit:
- Comment on: ‘Idiopathic inflammatory myopathies and antisynthetase syndrome: contribution of antisynthetase antibodies to improve current classification criteria’ by Greco et alAnnals of the Rheumatic Diseases, 2020
- Comparison of autoantibody specificities tested by a line blot assay and immunoprecipitation-based algorithm in patients with idiopathic inflammatory myopathiesAnnals of the Rheumatic Diseases, 2019
- Response to: ‘Detection of myositis-specific antibodies: additional notes’ by Infantino et alAnnals of the Rheumatic Diseases, 2019
- Response to: ‘2017 EULAR/ACR classification criteria for adult and juvenile idiopathic inflammatory myopathies and their major subgroups: little emphasis on autoantibodies, why?‘ by MalaviyaAnnals of the Rheumatic Diseases, 2018
- 2017 European League Against Rheumatism/American College of Rheumatology classification criteria for adult and juvenile idiopathic inflammatory myopathies and their major subgroupsAnnals of the Rheumatic Diseases, 2017